Google’s AlphaFold 3 AI predicts the very building blocks of life
Discover how companies are responsibly integrating AI in production. This invite-only event in SF will explore the intersection of technology and business. Find out how you can attend here.
Google DeepMind and Isomorphic Labs today unveiled AlphaFold 3, a new artificial intelligence model that could greatly accelerate the development of new drugs and treatments. The research published today in Nature reveals AlphaFold 3’s unparalleled ability to predict the intricate structures and interactions of life’s essential molecules, including proteins, DNA and RNA among others.
Advanced deep learning techniques promise to rapidly advance our understanding of biology at the molecular level, and could enable scientists to pursue novel therapies for a wide range of diseases more efficiently than ever before.
AlphaFold 3 is the latest iteration of the groundbreaking AI system developed by Google DeepMind, building upon the success of its predecessor, AlphaFold 2. Introduced in 2020, AlphaFold 2 made significant strides in protein structure prediction, enabling scientists to make discoveries in areas ranging from malaria vaccines to cancer treatments. The impact of AlphaFold has been recognized through numerous accolades, including the 2023 Breakthrough Prize in Life Sciences.
